Buclizine is an antihistamine and anticholinergic agent of the diphenylmethylpiperazine class, primarily utilized for its antiemetic properties in the treatment of motion sickness and nausea. By antagonizing… Read more
![Chemical structure of (R)-1-[(4-Chlorophenyl)phenylmethyl]piperazine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F300543-56-0-R-1-4-Chlorophenylphenylmethylpiperazine.png&w=3840&q=75)







Buclizine is an antihistamine and anticholinergic agent of the diphenylmethylpiperazine class, primarily utilized for its antiemetic properties in the treatment of motion sickness and nausea. By antagonizing histamine and muscarinic acetylcholine receptors, this drug effectively helps manage vomiting and related symptoms. Laboratories requiring accurate quantification and identification of this compound rely on high-quality reference standards, including the active pharmaceutical ingredient, to ensure precise analytical results. The associated products in this catalogue, such as process-related impurities, potential degradation products like 4-chlorobenzhydrol, and stable isotope-labelled compounds, are essential for rigorous impurity profiling and method validation. These materials facilitate compliance with pharmaceutical quality control standards, allowing researchers to develop sensitive, reliable assays for Buclizine and its metabolites throughout the drug development and regulatory testing lifecycle.